news

Curevo Vaccine Announces $60 Million Series A Financing to Support Clinical Development of Next Generation Subunit Vaccines

February 10, 2022 09:00 AM Eastern Standard Time SEATTLE--(BUSINESS WIRE)--Curevo Vaccine (Curevo), ...

SAHPRA approval Press Announcement 2021

CUREVO VACCINE ANNOUNCES THE APPROVAL TO CONDUCT A PHASE 1B CLINICAL TRIAL ...

Curevo Presenting at World Vaccine Congress (Washington) Sept 28 – Oct 1

Curevo Vaccine’s Steve Reed, PhD, Scientific Advisory and Executive Board member, and ...

Curevo Vaccine Announces Robust Antibody Response Results of Phase I Clinical Trial of Investigational Vaccine for Shingles CRV-101

Curevo Vaccine Announces Robust Antibody Response Results of Phase I Clinical Trial ...

Curevo Vaccine Announces Interim Results of Phase I Clinical Trial of CRV-101

September 26, 2019 12:00 PM Eastern Daylight Time SEATTLE–(BUSINESS WIRE)–Curevo, Inc., a ...

Curevo presents at IHW 2018 in Vancouver

Dr. Corey Casper presented CRV-101’s upcoming clincial studies in US and discussed its potential ...

GC Pharma to Establish Curevo

GC Pharma to Establish Curevo – a Seattle-based New Company Dedicated to ...